Live feed11:45:27·78dSECFilingvia QuantisnowAspire Biopharma Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Leadership Update, Regulation FD Disclosure, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.ASBP· Aspire Biopharma Holdings Inc.Health CareOriginal source
